Regulatory press releases

About CLS
IR
News & Media
Log in

Search for:

Therapy
- PrinciplesSimplicity and precision
- ProcedureStimulates the immune system
- Combined therapiesStudies are planned
- Clinical studies
- Intended purposeSolid tumors in different organs
- imILT – Scientific background
TRANBERG
- Thermal Therapy SystemA unique system
- Thermoguide softwareConcept of Thermoguide, soon to come
- Applikator kitFor a precise position
- CertifikatISO, EC, FDA
Publications
- Preclinical studiesThe research behind imILT®
- Clinical studiesStudies 1995–2015
- Posters
Contact
- ContactHow to reach us
- SupportFill out the form
- FAQQuestions & answers

Search for:

Welcome to Clinical Laserthermia Systems.
Please choose a country or region.

Subscribe to our mailing list

Email Address

Regulatory press releases

Home / News & Media / Regulatory press releases

News & Media

All press releases
Regulatory press releases
Other press releases
Events
Newsletter
Video
Subscribe

WHERE TO FIND US
CLS head office is located next door to the Lund University Cancer Research Center at Medicon Village in Lund, Sweden.

CLS
Scheelevägen 2
223 81 Lund
Sweden

Phone: 046-15 21 00
E-mail: info@clinicallaser.se

Subscribe to our news!

Besök oss på LinkedIn.

Version:
MM-2019-013 rev 2.0
Last Updated November 2021

About CLS
- Strategy
- Market
- Career
- History
- Privacy policy
IR
News & Media
Log in

Therapy
TRANBERG
Publications
Contact
- Contact
- Support
- FAQ

The TRANBERG®|Thermal Therapy System has not yet a market clearance for Immune stimulating interstitial laser thermotherapy (imILT®)
by the Food and Drug Administration (FDA) in the United States of America (USA)

(Svenska)

✕

Nyhetsbrev

Anmäl dig till vårt nyhetsbrev

We respect your privacy.